13  -0.05 (-0.38%)		03-16 16:00
Open: 13.73 High: 15.09 Volume: 108,544		Pre. Close: 13.05 Low: 11.56 Market Cap: 335(M)

Short term
Mid term
Targets	6-month :	17.41	1-year :	21.53
Resists	First :	14.91	Second :	18.43
Pivot price	10.54
Supports	First :	9.19	Second :	7.65
MAs	MA(5) :	11.36	MA(20) :	10.44
	MA(100) :	10.1	MA(250) :	9.9
MACD	MACD :	0.4	Signal :	0.1
%K %D	K(14,3) :	45.3	D(3) :	47.2
RSI	RSI(14): 89.2
52-week	High :	18.43	Low :	9.19

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ SMIH ] has closed above the upper band by 12.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 2309.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	15.1 - 15.18	15.18 - 15.23
Low:	11.42 - 11.5	11.5 - 11.55
Close:	12.87 - 13.01	13.01 - 13.09

Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.

Mon, 26 Feb 2024
B.E. Smith Seeking CEO for Deaconess Associations Incorporated - Hunt Scanlon Media

Tue, 19 Dec 2023
Summit Utilities opens new office in Fort Smith - talkbusiness.net

Mon, 21 Aug 2023
Funyuns and flu shots? Gas station company ventures into urgent care - Fierce healthcare

Wed, 03 May 2023
Reed Smith's 2023 Mental Health Summit: From Awareness to Action | Events - Reed Smith LLP

Tue, 14 Mar 2023
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS ... - PR Newswire

Wed, 08 Feb 2023
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF ... - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	20 (M)
Shares Float	15 (M)
Held by Insiders	0 (%)
Held by Institutions	73.5 (%)
Shares Short	13 (K)
Shares Short P.Month	7 (K)

EPS	1.48
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.24
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	451.3 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	8.78
PEG Ratio	0
Price to Book value	-56.53
Price to Sales	0
Price to Cash Flow	-257.43

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.